SPRY

ARS Pharmaceuticals, Inc.

10.64 USD
+0.20 (+1.87%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ARS Pharmaceuticals, Inc. stock is up 37.65% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 July’s closed higher than June. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
10 Jul 19:59 15 Nov, 2024 10.00 CALL 152 657
10 Jul 19:59 15 Nov, 2024 10.00 CALL 168 657

About ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.